East Hanover (United States)

Type: City
Name: East Hanover (United States)
Country: United States
Latitude: 40.82
Longitude: -74.370003
population: 12,194
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

MAGDI hires David Stuart, AIA, as Studio Director in New York City

New York, N.Y. – David J. Stuart, AIA has joined the prominent New York City architecture, design, and planning firm of Montroy Andersen DeMarco (MADGI) as Studio Director.  MADGI’s specialized studios serve multiple markets in the Greater New York area, ... [Published Building Design Construction - Jul 29 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Reports Summarize Multiple Sclerosis Study Results from Novartis (Characteristics influencing therapy switch behavior after suboptimal response to...

Reports Summarize Multiple Sclerosis Study Results from Novartis (Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis)By a News Reporter-Staff News Editor at Clinical ... [Published 4 Traders - Jul 23 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Report: Development IT hit hard in Novartis cutbacks

Over the first few months of 2014, Novartis ($NVS) quietly began laying off workers, shedding an estimated 3,000 jobs in four months. Now BioSpace has provided details of where the ax has fallen and why, with development IT teams suffering heavy job ... [Published Fierce Biotech IT - Jul 18 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

New Findings from Novartis Update Understanding of Clinical Trials and Studies (Efficacy of vildagliptin versus sulfonylureas as add-on therapy to...

New Findings from Novartis Update Understanding of Clinical Trials and Studies (Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies)By a News Reporter-Staff ... [Published 4 Traders - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

Latest Alzheimer's clinical trial will involve healthy, high-risk participants

On Monday, drugmaker Novartis and an Arizona-based research institute announced a new study to see whether two experimental drugs that attack amyloids can prevent or delay Alzheimer’s symptoms in healthy people who are at high risk of developing the incurable ... [Published Star Ledger - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Novartis AG Layoffs Announced: More Cuts May Be Looming

7/14/2014 1:09:07 AMJuly 14, 2014By Linda R. Bernstein, Pharm.D. , BioSpace.com Exclusive Story"It was like a slaughter," one long time Novartis employee commented.A source has reported that hundreds of Novartis employees worldwide recently lost their ... [Published BioSpace - Jul 14 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

The List: More than Mail, ZIP Code Used to Track NJ's Top 10 Payrolls

The U.S. Census Bureau annually issues a ZIP Code Business Patterns report as a way to track economic activity in smaller geographic areas and analyze changes over time. Businesses use the data to assess market potential, measure sales and advertising, ... [Published NJ Spotlight - Jul 14 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 1 reports

Novartis personalized cell therapy CTL019 receives FDA Breakthrough Therapy designation

EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment ... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Novartis Pharmaceutical Corporation

Novartis is a world leader in the research and development of products that protect and improve health and well-being. Our global mission is to discover, develop and successfully market innovative products to ease suffering and enhance the quality of ... [Published ClinicSpace - Jul 07 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Protection 1 Partners With Wounded Warriors Family Support Program

WWFS High Five Tour to Stop at 22 Protection 1 Locations Protection 1, the largest full service business and home security company in the U.S., today announced it will host events for the Wounded Warriors Family Support (WWFS) High Five Tour at Protection ... [Published PRWeb - Jun 30 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

‘Letters from Grandpa’ highlights letters written by Gene Kesselman

Gene Kesselman, 93, is passionate about leaving a living legacy to his grandchildren. He displays a Father’s Day note from his 22-year-old grandson, Steven, at his residence in West Caldwell. (Photo: PHOTOS BY TANYA BREEN/STAFF PHOTOGRAPHER)Gene Kesselman ... [Published Morris County Daily Record - Jun 30 2014]
First reported Apr 29 2014 - Updated Apr 30 2014 - 2 reports

Novartis gains FDA approval for Zykadia first therapy for patients with ALK NSCLC previously treated with the ALK inhibitor crizotinib

/PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Zykadia™ (ceritinib, previously known as LDK378) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell ... [Published BioPortfolio - Apr 29 2014]

Quotes

According to the news editors, the research concluded: "Younger patients with disease activity, especially MRI changes, are more likely to have their therapy switched sooner than patients who are older at the time of MS diagnosis and DMT initiation."
...According to news reporting originating in East Hanover, New Jersey , by NewsRx journalists, research stated, "Aims/hypothesis Randomised control trials (RCTs) do not always reflect real-life outcomes for glucose-lowering drugs. In this work we compared RCT and real-life data on the efficacy of the dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin or sulfonylureas when added to metformin."
...a prevention study," Michael Ryan, Novartis vice president and head of its neurodegeneration therapeutic division, said of the colloboration. "We expect that the findings will also inform future studies in a broader sporatic Alzheimer s disease population."
...8. The bulk of the cuts were at Amgen's headquarters in Thousand Oaks. "The majority of the positions were eliminated due to recently outsourced work" said spokeswoman Kristen Davis

More Content

All (21) | News (20) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
MAGDI hires David Stuart, AIA, as Studio Direct... [Published Building Design Construction - Jul 29 2014]
Reports Summarize Multiple Sclerosis Study Resu... [Published 4 Traders - Jul 23 2014]
Report: Development IT hit hard in Novartis cut... [Published Fierce Biotech IT - Jul 18 2014]
New Findings from Novartis Update Understanding... [Published 4 Traders - Jul 16 2014]
Latest Alzheimer's clinical trial will involve ... [Published Star Ledger - Jul 15 2014]
Novartis AG Layoffs Announced: More Cuts May Be... [Published BioSpace - Jul 14 2014]
The List: More than Mail, ZIP Code Used to Trac... [Published NJ Spotlight - Jul 14 2014]
Police blotter, 7/13: Armed robberies in Palmyr... [Published Lebanon Daily News - Jul 14 2014]
Head Pharmacist of West Orange Pharmacy Sentenc... [Published United States Department of Justice - Jul 10 2014]
Novartis Pharmaceutical Corporation [Published ClinicSpace - Jul 07 2014]
Novartis personalized cell therapy CTL019 recei... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
Caged Randolph workers raise money for pets [Published Morris County Daily Record - Jul 06 2014]
7 Tips for Sharing Finances in a Long-Term Rela... [Published US News & World Report - Jul 02 2014]
Protection 1 Partners With Wounded Warriors Fam... [Published PRWeb - Jun 30 2014]
‘Letters from Grandpa’ highlights letters writt... [Published Morris County Daily Record - Jun 30 2014]
Fireworks displays across the state [Published Morris County Daily Record - Jun 27 2014]
Remembering Len Soucy, founder, The Raptor Trust [Published Morris County Daily Record - Jun 26 2014]
Novartis gains FDA approval for Zykadia first t... [Published BioPortfolio - Apr 29 2014]
Novartis gains FDA approval for Zykadia™, first... [Published Yahoo! Finance - Apr 29 2014]
Tissue engineering methods and compositions [Published PharmCast - Apr 22 2014]
Mondelez International to Invest $130 Million i... [Published PR Newswire - Feb 06 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novartis personalized cell therapy CTL019 recei... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.